publication venue for
- Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy). 2015
- Systemic transthyretin amyloidosis in a patient with bent spine syndrome. 2013
- The blue man: a novel cutaneous manifestation of systemic amyloidosis. 2011
- Proteomic analysis shows that the main constituent of subepidermal localised cutaneous amyloidosis is not galectin-7.. 28. 2020
- Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration.. 21. 2014
- Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis.. 18 Suppl 1. 2011